CWM
VIR icon

CIBC World Markets’s Vir Biotechnology VIR Stock Holding History

CIBC World Markets’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$55.3K Sell
10,974
-9,170
-46% -$49.2K ﹤0.01% 1464
2025
Q1 		$131K Buy
+20,144
New +$179K ﹤0.01% 1556

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC World Markets's VIR Position: Q2 2025 in Review

CIBC World Markets reduced its Vir Biotechnology (VIR) stake by 46% in Q2 2025, selling an estimated $49.2K and leaving 10,974 shares worth $55.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

CIBC World Markets first reported a position in VIR in Q1 2025 and has held it in 2 quarters since. The position peaked at $131K in Q1 2025. 213 funds tracked by Wall St. Rank hold VIR as of Q2 2025.

  • CIBC World Markets held 10,974 shares of Vir Biotechnology worth $55.3K as of Q2 2025.
  • CIBC World Markets sold 9,170 Vir Biotechnology shares in Q2 2025, an estimated $49.2K.
  • Vir Biotechnology made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1464 holding.
  • CIBC World Markets first reported a position in Vir Biotechnology in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Vir Biotechnology position peaked at $131K in Q1 2025.
  • 213 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.